Member Info for Noody

didn't realise sorry..actual Article GlaxoSmithKline plc 47.5% Potential Upside Indicated by HSBC Posted by: Amilia Stone 27th February 2018 GlaxoSmithKline plc with EPIC/TICKER (LON:GSK) had its stock rating noted as �Reiterates� with the recommendation being set at �BUY� today by analysts at HSBC. GlaxoSmithKline plc are listed in the Health Care sector within UK Main Market. HSBC have set their target price at 1925 GBX on its stock. This is indicating the analyst believes there is a potential upside of 47.5% from the opening price of 1305 GBX. Over the last 30 and 90 trading days the company share price has decreased 44 points and decreased 22.5 points respectively. The 52 week high share price is 1724.5 GBX while the 52 week low for the share price is 1235.2 GBX. GlaxoSmithKline plc has a 50 day moving average of 1,314.69 GBX and a 200 day moving average of 1,315.22. There are currently 500,000,000 shares in issue with the average daily volume traded being 8,890,364. Market capitalisation for LON:GSK is �64,541,817,547 GBP.

https://www.***************************/glaxosmithkline-plc-47-5-potential-upside-indicated-by-hsbc/412746345

So nearly bought in last week......but didn't!!!! Well done and good luck....good day

The Independent: Energy price cap: Government to introduce legislation to limit how much power firms can charge. http://google.com/newsstand/s/CBIwjdr55Tc

https://www.fiercepharma.com/vaccines/glaxosmithkline-tops-its-peers-7-16b-2017-vaccine-sales

I agree.... The time to worry is if Woodford starts loading up :)

Whilst I thought the RNS was a grovelling apology for pretty poor performance and the fact that the company are bleeding customers, EPS down, adjusted earnings down etc....I have just perplexed myself by making an opening purchase at 1.43..... Why?????The company does not rely on high risk R&D, the products are cash generative and customers will come back from the cheaper " internet only customer service" deals they are on when they can't resolve their issues on the phone. But the main reason I've bought in (3-5 yr window) is that disclosed short interest in the company is a v meagre 0 .6%............just compare this to AA or provident etc......the big boys and hedge funds see no profit in shorting this indicating the bottom was in the 120's. Do I think this is a well managed stellar company???? God no. Do I think there is value here up to @2.20...oh yes

Seriously....you like the figures?? Operating profits -17% Earnings per share -25% Adjusted earnings -22% Even your CEO apologises for the very poor shareholders experience

I have been watching and considering my first purchase. Having read the CEO summary on top of RNS.......not buying here... He's not alone, but Christ these CEO's preside over awful performance but are happy to collect performance no bonuses....great job if you can get one!

Jack It is a huge liability....it has not gone anywhere but Has likely kept growing...if it gets out of hand and turns bad/ unmanageable longer term .....that is not priced in....

https://www.professionalpensions.com/professional-pensions/news/3007008/centrica-s-pensions-deficit-balloons-by-gbp1bn-over-2016

RB RNS....like for like sales flat...market not impressed....

https://portfolio-adviser.com/aurora-commits-pharma-upping-gsk-stake/.

https://www.warc.com/newsandopinion/news/gsk_has_a_nose_for_growth/40037

https://www.bloomberg.com/news/articles/2018-02-08/glaxo-s-advair-gets-boost-as-novartis-generic-is-denied-by-fda

https://www.bloomberg.com/news/articles/2018-02-08/glaxo-s-advair-gets-boost-as-novartis-generic-is-denied-by-fda

Another bunker day tomorrow

V funny.

Seeing as the Dow is off 350 ppts any rise today is good so a finish above 1300 will do. If the markets were reversed and the Dow was rising by +350...... we would be 50 pts higher.... Might not feel impressive but today has put an anchor down.....just need markets to stabilize

Just hot 13.30.... so a fair chance yes